Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

16 results
  1. ... i.e., with no clinical history of MDS, myeloproliferative disorder, or exposure to potentially ... of Secondary Complications Individuals with monosomy 7 and ...
  2. ... at any age. It usually begins as a myeloproliferative disorder, which is characterized by a high number of ... html:p><html:p >In addition to a myeloproliferative disorder, many people with 8p11 myeloproliferative syndrome develop lymphoma, ...
  3. ... t make red blood cells</li> <li>In myeloproliferative disorders, the bone marrow makes too many white blood ... related-topic >Myelodysplastic Syndromes</related-topic><see-reference ... ><information-category >Genetics</information-category>< ...
  4. ... one of a group of diseases called the myeloproliferative disorders. Other related entities include the following: Polycythemia vera. ... thrombocythemia. (Refer to the PDQ summary on Chronic Myeloproliferative ... CML CML is a clonal disorder that is usually easily diagnosed because the leukemic ...
  5. ... platelet count (e.g., essential thrombocythemia or other myeloproliferative disorders) Removal of VWF from circulation by aberrant binding ... Nichols et al 2008 , Castaman et al 2013 ]. Prevention of chronic joint disease is a concern for individuals with type 3 ...
  6. ... Cole SR, Buring JE. Aspirin in the primary prevention of cardiovascular disease in the Women's Health Study: effect of ... Stewart D, et al. Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients-- ...
  7. ... occur in a number of hematologic conditions including myeloproliferative and myelodysplastic disorders. Legg-Calvé-Perthes disease (OMIM 150600 ). Osteonecrosis may ...
  8. ... clinical trials are required.[ 102 , 103 ] Management and Prevention of Myeloma Bone Disease Myeloma bone disease is a consequence of increased ...
  9. ... rituximab, for patients with previously treated and untreated disease.[ 14 - 19 ][ Level of evidence: 3iiiDiv ] Prolonged, lower-dose approaches and attention to prevention of tumor lysis syndrome are suggested with this ...
  10. ... Institute) Also in Spanish Treatment Option Overview (Myelodysplastic/Myeloproliferative Neoplasms) ... What Causes Myelodysplastic Syndromes? (American Cancer Society) Also ...
previous · 1 · 2 · next